Aliri has extensive experience supporting the precision bioanalysis of ophthalmic therapies including:
- Method demonstration, development, optimization, fit-for-purpose & GLP validation, and regulatory sample analysis
of ocular tissue and supporting matrices - Challenging large and small molecule ophthalmic drugs, including, prostaglandin analogs, peptides,
hormones, polysaccharides, allergen biomarkers, siRNA, oligonucleotidesWhole-eye spatial imaging using Quantitative
Mass Spectrometry Imaging (QMSI) to visually understand how your molecule performs in the microenvironment.
Download the fact sheet to learn more.